Partnering – Collaborative Research Services
Sareum is a leading provider of structure-based drug discovery research services.
Our approach:
- ‘Clean’ deal
- Compound IP owned by customer
- No requested IP 'reach-through'
- Research payments and success milestones
- Project flexibility - from single to multi-target collaborations
- Open collaborative framework
- Access to years of drug discovery experience
Sareum’s collaborative research partners span across global top 5 Pharmaceutical companies who do not have the capacity to conduct all their own structure based discovery research to smaller biotechnology companies that need to generate novel chemical matter in critically important internal research programmes.
Our platform is scalable and our partnering approach is flexible enough to cover single target structure solutions through to multi-target, multi-year collaborations to generate novel pre-clinical candidates.
If you are interested in accessing Sareum’s expertise in structure and fragment screening based drug discovery please contact us: BD@sareum.co.uk.
Requires RSS news reader
Requires MS Word
Requires Adobe Acrobat Reader